Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advancis predicts loss after delayed drug launch
Total revenue for 2006 from sales of Keflex products is now expected to be approximately $7 million to $10 million, down from prior expectations of $16 million to
Total revenue for 2006 from sales of Keflex products is now expected to be approximately $7 million to $10 million, down from prior expectations of $16 million to
The phase I study will be conducted in Uganda and is designed to test the safety of injecting newborns with the vaccine, formally known as ALVAC-HIV. Researchers estimate
The drug has also been granted fast track designation by the Food and Drug Administration. Fast track is a program designed to facilitate the development of new drugs
The phase III trial will evaluate the efficacy of Saforis Powder in UpTec for oral suspension. “Based upon the FDA’s request, we will be evaluating options to maximize
The company will now operate as part of a newly created wholly owned subsidiary of Endo Pharmaceuticals. The transaction includes an up-front payment of up to $20 million,
Boehringer Ingelheim’s acquisition of Zantac will improve the company’s market presence in over-the-counter (OTC) products and could strengthen its presence in the US market. Zantac is regarded as
Nexium, a proton pump inhibitor, is already is indicated for the treatment of gastroesophageal reflux disease and heartburn. Nexium is also is used to reduce the risk of
The approval is a special protocol agreement between Avax and the FDA regarding the trial design and surrogate endpoints to be used as a basis of filing for
Final approval is expected upon expiry of the product patent on December 29, 2007. Upon final approval, Teva’s risperidone will be the AA-rated generic equivalent of Risperdal which
Peregrine is following the lead of many pharmaceutical companies including Pfizer, GlaxoSmithKline, Roche and Eli Lilly that have recently been conducting major clinical trials in India, taking advantage